期刊文献+

新型冠状病毒核酸和抗体检测临床应用专家共识 被引量:38

下载PDF
导出
摘要 当前,复工复产逐步推进,疫情境外输入压力不断增大以及无症状感染者存在一定传播风险等,这对新型冠状病毒检测工作提出了新的要求。上海市卫生健康委员会贯彻《关于进一步做好疫情期间新冠病毒检测有关工作的通知》[1]精神,发布加强本市医疗机构新型冠状病毒检测工作的通知,强调结合国家联防联控机制文件,做好贯彻落实工作。文件指出,原则上二级以上综合性医疗机构应当建立符合生物安全二级及以上标准的临床检验实验室,具备独立开展新型冠状病毒检测的能力,常态化防控要提升检测能力,大规模开展核酸和抗体检测。这有利于精准防控,保障群众健康,推动全面复工复产。要提高检测技术水平,抓紧扩大更简便、高效的检测设备的生产规模和商业化应用,努力做到应检尽检、愿检尽检。这对诸多医院检验科的检验流程、检验质量和生物安全提出了更高的要求。
作者
出处 《国际检验医学杂志》 CAS 2020年第14期1665-1669,共5页 International Journal of Laboratory Medicine
  • 相关文献

参考文献3

二级参考文献23

  • 1Roychowdhury S,Chinnaiyan AM. Translating cancer genomesand transcriptoraes for precision oncology [ J]. CA Cancer J Clin,2016,66(1) :75-88. DOI: 10. 3322/caac. 21329.
  • 2Porto G, Brissot P,Swinkels DW, et al. EMQN best practiceguidelines for the molecular genetic diagnosis of hereditaryhemochromatosis ( HH) [J/OL]. Eur J Hum Genet, 2015 [2015-12-14 ]. http://www. ncbi. nlm. nih. gov/pubmed/? term =26153218. [ published online ahead of print Jul 8,2015 ]. DOI:10.1038/ejhg. 2015.128.
  • 3Mr6zek K, Marcucci G, Nicolet D, et al. Prognostic significanceof the European LeukemiaNet standardized system for reportingcytogenetic and molecular alterations in adults with acute myeloidleukemia[J].J Clin Oncol, 2012, 30(36) :45154523. D01:10.1200/100.2012.43.4738.
  • 4Field N, Cohen T, Struelens MJ, et al. Strengthening theReporting of Molecular Epidemiology for Infectious Diseases(STROME-ID) : an extension of the STROBE statement [ J ].Lancet Infect Dis, 2014, 14(4) :341-352. DOI: 10.1016/S1473-3099(13)703244.
  • 5Burgunder JM, Schols L, Baets J, et al. EFNS guidelines for themolecular diagnosis of neurogenetic disorders : motoneuron,peripheral nerve and muscle disorders [ J ]. Eur J Neurol, 2011,18(2) :207-217. DOI:10.1111/j. 1468-1331.2010.03069. x.
  • 6Mack SJ, Milius RP, Gifford BD, et al. Minimum information forreporting next generation sequence genotyping ( MIRING ):Guidelines for reporting HLA and KIR genotyping via nextgeneration sequencing[ J ]. Hum Immunol, 2015 , 76(12):954-962. DOI: 10.1016/j. humimm. 2015.09.011.
  • 7Hardisty EE,Vora NL. Advances in genetic prenatal diagnosisand screening[ J]. Curr Opin Pediatr, 2014,26(6) :634-638.DOI: 10.1097/MOP. 0000000000000145.
  • 8Hu L,Zhuo W,He YJ, et al. Pharmacogenetics of P450oxidoreductase : implications in drug metabolism and therapy [ J ].Pharmacogenet Genomics, 2012, 22 ( 11 ) : 812-819. DOI: 10.1097/FPC. 0b013e328358d92b.
  • 9Scheuner MT, Hilbome L, Brown J,et al. A report template formolecular genetic tests designed to improve communicationbetween the clinician and laboratory [ J ]. Genet Test MolBiomarkers, 2012,16(7):761-769. DOI: 10. 1089/gtmb. 2011.0328.
  • 10Claustres M, Ko2ich V, Dequeker E,et al. Recommendations forreporting results of diagnostic genetic testing ( biochemical,cytogenetic and molecular genetic) [ J]. Eur J Hum Genet, 2014,22(2) :160470. D01;10.1038/ejhg. 2013.125.

共引文献123

同被引文献312

引证文献38

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部